![]() FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. | ![]() Innoprot Innoprot is a biotechnology company that provides products and technologies for cell-based assays in drug discovery and development. | Leinco Technologies Leinco Technologies is a company providing custom development and manufacturing services for the biotechnology industry. | ||
Founding Date | Founding Date 1992 | Founding Date 1993 | Founding Date 2007 | Founding Date 1992 |
Type | Type Public | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Rancho Cucamonga, US HQ El Cajon, US El Cajon, US | Locations San Francisco, US HQ | Locations Derio, ES HQ | Locations Fenton, US HQ |
Employees | Employees 1011% increase | Employees 53115% increase | Employees 16 | Employees 353% increase |
Valuation ($) | Valuation ($) 10.1 m | Valuation ($) 30.7 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $2.2m (FY, 2025) | Revenue (est.) $6.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $899k (FY, 2025) | Cost of goods $556k (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $1.3m (FY, 2025) | Gross profit $5.9m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($2.4m) (FY, 2025) | Net income $183.5m (FY, 2025) | Net income N/A | Net income N/A |

FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View company
Innoprot is a biotechnology company that provides products and technologies for cell-based assays in drug discovery and development.
View companyLeinco Technologies is a company providing custom development and manufacturing services for the biotechnology industry.
View company